Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-24
SponsorMedical College of Wisconsin
About this trial
This project will apply a novel non-nutritive sweetener (NNS) dietary assessment tool with measurement of circulating NNS levels in a pediatric population, allowing correlation of NNS exposure to clinically meaningful cardiometabolic health outcomes.
Eligibility criteria
Qualifiers
Aged 15-24 years
Clinical diagnosis of type 1 diabetes, requiring insulin therapy, of ≥ 1 to < 10 years duration.
Last available HbA1c ≤ 8.5% (obtained by chart review in Children's Wisconsin Diabetes Clinic patients or verbally by individuals not receiving diabetes care at Children's Wisconsin)
Current use of an FDA approved automated insulin delivery (AID) system
Disqualifiers
Any disease other than type 1 diabetes that affects glucose, sex steroid, or fat metabolism such as polycystic ovary syndrome or hypercortisolism
Any medication use that may affect glucose, sex steroid, or fat metabolism such as metformin or glucocorticoids
Half or full sibling already participating in this study
Known cardiovascular disease such as hypertension or atherosclerosis, and/or use of an anti-hypertensive medication
Trial design
Treatments tested in this trial
- Cherry Sports Drink
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov